Editor’s note: This healthcare vendor evaluation checklist is designed for health plans and self-funded employers evaluating vendors that support payment integrity and recovery programs. It explains how performance claims like ROI, recovery rates, and AI-driven results are defined, measured, and validated in real-world operations before contracts are signed.
If you lead payment integrity or financial performance at a health payer, you’ve likely reviewed many vendor presentations highlighting strong results, like claims of outsized return on investment (ROI), high recovery rates, or AI-powered identification capabilities.
In many cases, those metrics are not incorrect. In payer evaluations and request for proposal (RFP) reviews, those results often reflect specific assumptions, definitions, and methodologies used for vendor performance management and reporting.
How vendors build those measures often matters more than the headline number, especially when finance, audit, or a risk manager reviews results for oversight and regulatory compliance.
Rather than prescribing which metrics matter most, this post focuses on how vendors define and produce performance metrics. This approach helps distinguish solutions that align with operational goals from those that require closer review.
The questions apply across payment integrity domains, including:
- Coordination of benefits
- Subrogation
- Claims validation
- Clinical editing
- Diagnosis-related group (DRG) review, fraud, waste and abuse
- Overpayment recovery
- And more
Use this checklist during vendor evaluations, RFPs, and renewal discussions when you need clarity and confidence.
Why healthcare vendor metrics are easy to misinterpret
In payment integrity and recovery programs, performance metrics often compress a long, multi-step process into a single number. That compression is useful, but it also hides important assumptions tied to service levels, data availability, operational workflows, and member outcomes.
For example:
- What stage of the process is being measured?
- What populations are included or excluded?
- Over what time horizon?
- Against what baseline?
When vendors don’t state assumptions clearly, metrics can look more definitive than they are. That often creates misalignment among payer teams, vendors, and stakeholders accountable for contractual obligations.
This is especially important as more organizations evaluate technology-enabled solutions, including those that incorporate automation and artificial intelligence (AI). Technology is most effective when paired with operational discipline and shared definitions.
Common healthcare performance metrics, and why context matters
Before reviewing the checklist, it’s important to note that many healthcare performance metrics give helpful signals. In payer vendor evaluations, these metrics matter most when you connect them to real operations, agreed service levels, member outcomes, and continuous improvement over time.
Cost avoidance
Teams often use cost avoidance to show preventive impact. It is most informative when you tie it to verified downstream claim behavior and consistent assumptions. Without that link, it is hard to tell whether projected cost savings will materialize or actually reduce costs.
Identification rates
Identification rates can help assess signal detection and analytic coverage. In practice, they are incomplete without corresponding conversion and realization data that show how identified opportunities translate into approved actions, financial outcomes, and improved response time.
Percent of lien recovered
This metric is relevant in certain recovery contexts, particularly subrogation. Its usefulness depends on understanding the underlying sources of recovery and the portion of lien values that are realistically recoverable given legal, settlement, and regulatory requirements.
ROI
ROI can be a meaningful summary metric when costs, timing, attribution, and baselines are fully specified. In vendor reviews, ambiguity around any of these elements can materially change how ROI is interpreted by finance leaders, compliance teams, and executives accountable for vendor relationships.
Each of these metrics can be useful in the right setting. On their own, however, they rarely provide enough context to support informed decision-making during vendor selection, contracting, or ongoing vendor performance management.
The healthcare vendor evaluation checklist
At last, you’ve made it to the checklist.
The questions below are ones that often arise during healthcare payer vendor evaluations, RFPs, renewals, and performance reviews. It helps payers and vendors align on definitions, measurement, and interpretation before finalizing and signing contract terms.
1. What exactly is being counted as value?
Ask vendors to clearly define the unit of value they report. In practice, this often includes one or more of the following:
- Identified opportunities
- Approved adjustments
- Realized (net) cash
- Prevented payments
Why it matters: Different value types serve different purposes. In payer organizations, finance teams prioritize realized financial impact, while operational teams may also place value on prevention and early identification. Misalignment is one of the most common sources of downstream disagreement.
2. At what stage in the process is performance measured?
Clarify whether reported results reflect:
- Identification
- Action taken
- Approval
- Realization
Why it matters: Each stage reflects a different kind of effectiveness. Experience across payment integrity programs shows that strong identification alone does not reliably translate into strong realization without sustained operational follow-through, and recovery workflows, including appeal and denial management.
3. What is included, and what is excluded, from the reported population?
Request a clear description of:
- Lines of business included
- Claim types excluded
- Dollar thresholds
- File age limits
- Geographies or provider segments out of scope
Why it matters: Exclusions are often necessary for valid operational reasons. Without clear definitions, performance results are often misinterpreted as programs scale or move into finance, audit, or executive review.
4. Are results based on a sample or the full population?
Ask whether reported outcomes reflect:
- A representative sample
- A pilot cohort
- The entire eligible population
Why it matters: Sampling can be appropriate early in a program, particularly during pilots. Population-level reporting, however, provides a more accurate picture of sustained performance and operational impact.
5. What denominator is used for percentage-based metrics?
For any percentage, clarify:
- What the denominator is
- Who defines it
- Whether it can be replicated internally
Why it matters: Percentages are only meaningful when the denominator is stable, transparent, and consistently applied. Small changes in denominator definition can materially alter perceived performance.
6. How is available recovery estimated, if applicable?
In recovery-focused programs, ask how vendors distinguish between:
- Amount paid
- Lien amount
- Amount realistically recoverable
Why it matters: Availability constraints like policy limits, settlements, and legal considerations significantly shape recoverable outcomes. In subrogation, raw lien values rarely reflect true recovery potential.
7. What is the time horizon for reported results?
Request clarity on:
- Average time to realization
- Distribution over time (e.g., 90 days, 1 year, 3 years)
- Differences by claim size or complexity
Why it matters: Timing affects cash flow, forecasting accuracy, and internal resource planning. Programs with similar total impact can look very different when timing is considered.
8. How is attribution handled across overlapping programs?
If multiple initiatives exist, such as coordination of benefits, subrogation, audits, or clinical reviews, ask how vendors:
- Prevent double counting
- Attribute shared outcomes
- Coordinate with internal teams
Why it matters: Clear attribution protects payer credibility and supports accurate internal reporting. It also reduces friction when multiple vendors or internal teams touch the same claims.
9. How are reversals, appeals, or false positives reflected?
Ask how vendors account for:
- Overturned decisions
- Appeals outcomes
- Net vs. gross impact
Why it matters: Sustainable performance reflects accuracy and durability, not just volume. Programs that do not account for reversals can overstate their long-term value.
10. Can performance be independently validated?
Ask whether:
- Logic can be reviewed
- Calculations can be replicated
- Data inputs are documented
Why it matters: Transparency supports trust and reduces disputes over performance interpretation, particularly as programs mature and scrutiny increases.
11. How sensitive are results to data quality?
Discuss:
- Required data elements
- Performance degradation with incomplete data
- Implementation learning curves
Why it matters: In real-world payer environments, data is rarely perfect. Strong partners anticipate data limitations and design programs that remain effective under those conditions.
12. What baseline is used for comparison?
Clarify whether improvements are measured against:
- Historical internal performance
- External benchmarks
- Modeled estimates
Why it matters: Improvement claims depend heavily on the starting point. Without clarity on the baseline, it is difficult to interpret reported gains.
13. What commitments are made, and how are they measured?
Whether formal guarantees exist or not, ask:
- What is being committed?
- How is success defined?
- How are disagreements resolved?
Why it matters: Clear commitments reduce ambiguity and help prevent future friction once programs are operational.
14. How does performance vary by complexity and size?
Ask for stratified results by:
- Claim size
- Case complexity, and
- Resolution time
Why it matters: Across many payment integrity domains, a small subset of cases drives the majority of impact. Understanding this distribution supports better forecasting and prioritization.
15. What operational effort is required from payer teams?
Discuss:
- Internal staffing needs
- Review or approval steps
- Ongoing governance
Why it matters: True value includes operational sustainability. Programs that appear strong on paper can underperform if internal effort requirements are underestimated.
16. Where, specifically, is automation or AI applied?
Rather than focusing on labels, ask:
- Which steps are automated?
- What work is reduced?
- How do accuracy and outcomes improve?
Why it matters: Clear understanding of how automation and AI are applied supports realistic expectations and more effective oversight.
17. How does the solution support, rather than replace, expert judgment?
Ask how technology:
- Removes low-value work
- Improves decision quality
- Supports experienced operators
Why it matters: Long-term success in healthcare operations depends on effective collaboration between people and systems.
Signals that merit further discussion (not automatic deal-breakers)
When evaluating healthcare vendors, it’s tempting to sort findings into binary categories, like green flags and red flags. In practice, most situations fall into a more useful middle ground.
The signals below don’t indicate that a vendor is unqualified or acting in bad faith. More often, these signals reflect different assumptions, measurement of maturity, or operational complexity, including data governance, and regulatory compliance.
What matters is whether these signals prompt productive clarification or remain unresolved.
Use these points as conversation starters to strengthen vendor relationships and improve shared understanding:
1. Metrics presented without clear definitions
What this often means:
Vendors may use internal shorthand, especially with long-standing clients who already know their measurement conventions.
Terms like “savings,” “recoveries,” or “value delivered” are overloaded in healthcare. Two teams can use the same word to describe very different things.
Why it’s worth discussing:
Undefined metrics create room for misinterpretation later, especially once results are reviewed by finance, audit, or executive leadership.
What to explore together:
- How does the vendor define each metric operationally?
- At what point in the workflow is it measured?
- Which teams typically rely on this metric (ops vs finance vs compliance)?
Clarity here protects you and helps the vendor ensure their work is evaluated fairly.
2. Heavy reliance on projections without practical outcomes
What this often means:
The vendor may be early in a solution’s lifecycle, operating in a domain where outcomes take time to materialize, or focused on prevention rather than recovery.
Projections can support planning, especially in preventive programs, but you need to understand how vendors frame them.
Why it’s worth discussing:
Finance leaders make different decisions based on projected impact versus realized impact. Mixing the two without distinction can create unrealistic expectations.
What to explore together:
- Which results are projected, and which are realized?
- Over what timeframe do projections typically convert to realized value?
- How accurate have past projections been compared to eventual outcomes?
Work to align projections with appropriate governance.
3. Limited visibility into exclusions
What this often means:
Exclusions may exist for legitimate reasons, like data availability, regulatory constraints, operational readiness, or agreed-upon scope limitations. However, exclusions are sometimes documented informally or assumed to be understood rather than called out explicitly.
Why it’s worth discussing:
Exclusions shape performance as much as execution does. If they’re not well understood, results can appear stronger or weaker than expected once scaled.
What to explore together:
- What categories of claims, members, or providers are out of scope, and why?
- Are exclusions static, or do they change over time?
- How might exclusions affect performance as the program expands?
This conversation often surfaces opportunities to expand scope responsibly or to recalibrate expectations early.
4. Difficulty explaining performance variance
What this often means:
Healthcare operations are complex. Performance naturally varies by geography, line of business, provider mix, and case complexity. If a vendor struggles to explain variance, they may report for averages instead of diagnostics.
Why it’s worth discussing:
Understanding variance is essential for:
- Forecasting
- Scaling
- Identifying where intervention matters most
Lack of clarity here doesn’t imply poor performance, but it does limit your ability to manage it proactively.
What to explore together:
- Where does performance vary most, and why?
- How do outcomes differ by complexity or dollar size?
- What operational levers improve underperforming segments?
Vendors who engage at this level are often strong partners, even when top-line metrics look uneven.
How to use these signals constructively
Think of these signals as prompts for alignment. Address these issues early to improve adherence to contractual obligations, coordination across teams and partners, and long-term relationships.
Look for vendors who are willing to work through these signals with transparency. That willingness, more than any single metric, is often the strongest indicator of a successful partnership.
Get a one-page version of the checklist
The content on this page is subject to our Terms of Use.
